GlucoCare offers a non-invasive device for diabetic risk assessment, eliminating the need for needles and recurring consumable costs. Its mobile application provides results within minutes, offering a pain-free and user-friendly alternative for routine health monitoring.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional methods for assessing diabetic risk require invasive procedures and often involve recurring costs for consumables. This can lead to patient discomfort and financial barriers for consistent health monitoring.
Solution
GlucoCare provides a non-invasive device for diabetic risk assessment, eliminating the need for needles and associated discomfort. The device pairs with a mobile application, enabling users to obtain results within minutes. This approach offers a pain-free and user-friendly alternative for routine health check-ups, with a one-time purchase eliminating ongoing expenses.
Target Audience
Individuals seeking a comfortable and cost-effective method for monitoring their diabetic risk, particularly those who prefer non-invasive health assessment tools.
Features
- Non-invasive sensor technology for glucose level estimation.
- Mobile application integration for data capture and result display.
- Real-time result generation within a 5-minute processing window.
- One-time hardware purchase model, eliminating recurring consumable fees.
- Reported accuracy of 80% for diabetic risk assessment.